Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA] class drugs

3 results
  • epclusa - velpatasvir and sofosbuvir tablet, film coated

    (Velpatasvir And Sofosbuvir)
    Gilead Sciences, Inc.
    Epclusa treats chronic hepatitis C virus (HCV) genotypes 1–6 in adults and children aged 3 and older. It is used with or without cirrhosis; patients with decompensated cirrhosis take it in combination with ribavirin.
  • vosevi - sofosbuvir, velpatasvir, and voxilaprevir tablet, film coated

    (Sofosbuvir, Velpatasvir, And Voxilaprevir)
    Gilead Sciences, Inc.
    Vosevi treats chronic hepatitis C (genotypes 1–6) in adults without cirrhosis or with compensated cirrhosis who were previously treated with an NS5A inhibitor, or genotype 1a/3 patients previously treated with sofosbuvir without an NS5A inhibitor.